Literature DB >> 1718830

An enzyme-linked immunosorbent assay (ELISA) for prostate-specific antigen.

L I Stowell1, L E Sharman, K Hamel.   

Abstract

A sandwich ELISA for human prostate-specific antigen (PSA) is described. Optimal assay conditions, resulting in a sensitive assay with a low background, are presented. The method uses a hyperimmune antiserum produced in the New Zealand white rabbit, against human semen PSA. The IgG fraction of the antiserum was conjugated with horseradish peroxidase and used in the sandwich ELISA method. The anti-PSA IgG showed no cross reactions with saliva, normal blood, female urine, vaginal fluid, or menstrual blood. On occasions, a blood sample showed a non-specific cross-reaction, which was detected by non-immune rabbit IgG. This reaction could be caused by rheumatoid factors, as indicated by experiments with a series of known IgG and IgM rheumatoid antibodies, although other heterophilic antibodies could not be eliminated. The recovery of PSA added to blood plasma, saliva and vaginal fluid was affected by three factors; (a) protein concentration (dilution) of body fluid; (b) nature of the protein; and (c) amount of PSA added.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718830     DOI: 10.1016/0379-0738(91)90141-5

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  9 in total

1.  Simultaneous determination of free and total prostate-specific antigen by a magnetic particle-based time-resolved fluoroimmunoassay.

Authors:  Bin Zhou; Jue Zhang; Zhongwei Lv; Jun Fan; Yi Zhang; Biao Huang
Journal:  J Clin Lab Anal       Date:  2017-01-19       Impact factor: 2.352

2.  Applicability of ELISA detection of statherin for forensic identification of saliva.

Authors:  Tomoko Akutsu; Ken Watanabe; Yoshihito Fujinami; Koichi Sakurada
Journal:  Int J Legal Med       Date:  2009-12-02       Impact factor: 2.686

3.  Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards.

Authors:  Margaret C Snead; Athena P Kourtis; Carolyn M Black; Christine K Mauck; Teresa M Brown; Ana Penman-Aguilar; Johan H Melendez; Maria F Gallo; Denise J Jamieson; Maurizio Macaluso
Journal:  Contraception       Date:  2012-12-04       Impact factor: 3.375

4.  Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?

Authors:  Margaret C Snead; Athena P Kourtis; Johan H Melendez; Carolyn M Black; Christine K Mauck; Ana Penman-Aguilar; Dorothy M Chaney; Maria F Gallo; Denise J Jamieson; Maurizio Macaluso; Gustavo F Doncel
Journal:  Contraception       Date:  2014-03-25       Impact factor: 3.375

5.  Oxidative stress indicators in patients with prostate disorders in Enugu, South-East Nigeria.

Authors:  Romanda Duru; Obioma Njoku; Ignatius Maduka
Journal:  Biomed Res Int       Date:  2014-04-24       Impact factor: 3.411

6.  Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.

Authors:  Shahana Sarwar; Mohammed Abdul Majid Adil; Parveen Nyamath; Mohammed Ishaq
Journal:  Prostate Cancer       Date:  2017-01-12

7.  The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS.

Authors:  Patrick Temi Adegun; Philip Babatunde Adebayo; Samuel Adeniran Atiba
Journal:  Asian J Urol       Date:  2015-06-24

8.  Catalytic Gold Deposition for Ultrasensitive Optical Immunosensing of Prostate Specific Antigen.

Authors:  Laura Cid-Barrio; Jorge Ruiz Encinar; José Manuel Costa-Fernández
Journal:  Sensors (Basel)       Date:  2020-09-16       Impact factor: 3.576

9.  Forensic Body Fluid Identification by Analysis of Multiple RNA Markers Using NanoString Technology.

Authors:  Jong-Lyul Park; Seong-Min Park; Jeong-Hwan Kim; Han-Chul Lee; Seung-Hwan Lee; Kwang-Man Woo; Seon-Young Kim
Journal:  Genomics Inform       Date:  2013-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.